Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
|
|
- Cecily Roberts
- 5 years ago
- Views:
Transcription
1 Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive Sciences Speaker Disclosure: I have nothing to disclose May 25, 217 Learning Objectives To describe risk factors and symptoms for the most common gynecologic malignancies Gynecologic Cancers are many diseases To identify appropriate individuals for HPV vaccination To offer genetic counseling and testing to women with ovarian cancer and their immediate family members as appropriate To identify women with endometrial cancer at risk for Lynch Syndrome (And gestational trophoblastic tumors)
2 Causes of Cancer Cancer Statistics, 216 Estimates U.S. Women Est. New Cancer Cases Breast 246,66 Lung 16,47 Colon/Rectum 63,67 Uterus 6,5 Thyroid 49,35 NH Lymphoma 32,41 Melanoma 29,51 Ovary 22,28 Cervix 12,99 Est. Cancer Deaths Lung 72,16 Breast 4,45 Colon/Rectum 23,17 Pancreas 2,33 Ovary 14,24 Uterus 1,47 Leukemia 1,27 NH Lymphoma 8,63 Cervix 4,12 Cancer in a Global View Cervical Cancer Survival Overall: 87% at One Year 69% at Five Years Diagnosis 5-year Survival Stage I Stage II Stage III Stage IV Local Regional Distant Overall
3 Cervical CA--Age Distribution Cervical Cancer Histology % 1-25% Squamous Adeno AdenoSqamous Clear Cell Other >8 3% <1% 3-5% Cervical Cancer Risk Factors HPV infection Early age at 1 st birth Early age at 1 st intercourse Long term oral contraceptive use High parity Low socioeconomic status Smoking?Genetic factors?other sexually transmitted agents (chlamydia) Cervical Cancer--Symptoms Postmenopausal bleeding Irregular menses Postcoital bleeding Vaginal discharge Pain Asymptomatic
4 Cervical CA--Diagnosis HPV types & Cancer risk Pap smear for screening Biopsy for abnormal cervix HPV TYPE CANCER RISK 6,11, Low to nil 31,33,35,39,51-53,58,59,66,68 Intermediate 16,18, 45, 56 High Screening for cervical cancer Primary prevention: HPV vaccines 2 approaches are currently in use in the USA Cytology (Pap test) every 3 years Cytology (Pap test) plus HPV testing every 5 years HPV testing detects the high risk HPV types associated with cervical cancer Bivalent (2vHPV): HPV16 and18 Quadrivalent (4vHPV): HPV 6, 11, 16 and 18 9-valent (9vHPV): HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58
5 CDC Recommendations for HPV vaccination Initiate routine HPV vaccination at age 11 or 12 years. Cervical Cancer Take-home Summary Primary prevention of cervical cancer: HPV vaccination before exposure to HPV The vaccination series can be started beginning at age 9 years. Vaccination is also recommended for females aged 13 through 26 years and for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3- dose series Secondary prevention of cervical cancer: screening for detection and treatment of cancer precursors Males aged 22 through 26 years may be vaccinated. MMWR March 27, 215 / 64(11);3-34 Ovarian Cancer Survival Overall: 78% at One Year 46% at Five Years Diagnosis Stage I Stage II 5-year Survival Stage III Stage IV Stage I Stage II Stage III Stage IV Overall Ovarian Cancer: pathogenesis
6 Ovarian Cancer: Risk Factors Germline evaluation of ovarian cancer Increasing age Family history of ovarian, fallopian tube, primary peritoneal cancer, or premenopausal breast cancer Personal history of premenopausal breast cancer Infertility / never becoming pregnant Oral contraceptive pill use is protective 36 consecutive women with primary ovarian, tubal, peritoneal CA at the University of Washington, Screened for 21 germline mutations by genomic sequencing 11% BRCA1 6% BRCA2 6% Other: BARD1, BRIP1, CHEK2, MRE11A, MSH6, NBN, PALB2, RAD5, RAD51C, or TP53 31% with no family history of breast/ovarian cancer 63% less than age 6 Walsh et al, Proc Natl Acad Sci USA Personalized Gynecologic Cancer Care through Genetics Helen Diller Family Comprehensive Cancer Center 1/27/15 Causes of Ovarian Cancer Sporadic Hereditary (15-24%) Sporadic Women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should receive genetic counseling and be offered genetic testing, even in the absence of a family history. Walsh et al, Proc Natl Acad Sci USA 211 SGO Clinical Practice Guideline Genetic Screening for Ovarian Cancer October Personalized Gynecologic Cancer Care through Genetics Helen Diller Family Comprehensive Cancer Center 1/27/15 24 Personalized Gynecologic Cancer Care through Genetics Helen Diller Family Comprehensive Cancer Center 1/27/15 3
7 BRCA1 / BRCA2 & Survival Outcome Homologous Recombination Pooled analysis of 26 observational studies, 99 BRCA1 mutation carriers, 34 BRCA2 mutation carriers, 2666 noncarriers, from Differences remained after adjustment for age, stage, histology Bolton et al, JAMA BRCA Mutation & Homologous Recombination Deficiency as a Target Ovarian Cancer: Know the symptoms Pelvic or abdominal pain Difficulty eating or feeling full quickly Bloating Urinary symptoms (urgency & frequency) 27
8 Ovarian Cancer: Prevention Ovarian Cancer: Routine Screening is NOT recommended Oral contraceptive pills decrease ovarian cancer risk by up to 5% Screening test must be noninvasive Even 6 months is beneficial Screening test must be inexpensive Benefits last for 15 years Detection of tumors at an early stage to allow more successful treatment Even in BRCA1/BRCA2 mutation carriers, any use of OCPs yields odds ratio of.5. CA125 Elevated in 8% of epithelial ovarian cancers but only 25-5% of Stage I. May be elevated in benign conditions: fibroids, adenomyosis, endometriosis, pelvic inflammatory disease, pregnancy, menstruation CASH Study, N Eng J Med 1987 Narod et al, N Engl J Med 1998 Narod et al, N Engl J Med, 1998 Incremental Risk of Ovarian Cancer Risk-reducing Salpingo-oophorectomy Prospective multicenter cohort study of 2482 women with BRCA1 & BRCA2 mutations, PROSE consortium Decrease in breast cancer risk Lower all- cause mortality HR.4 ( ) Lower breast cancer- specific mortality HR.44 ( ) Lower ovarian cancer- specific mortality HR.21(.6-.8) Domchek et al, JAMA 21 Antoniou et al, Am J Hum Genet Personalized Gynecologic Cancer Care through Genetics Helen Diller Family Comprehensive Cancer Center 1/27/15
9 Ovarian Cancer Take-home Summary Endometrial Cancer Survival Prevention of ovarian cancer: Genetic testing and risk-reducing surgery for high risk individuals. Oral contraceptive pills & salpingectomy as appropriate Overall: Diagnosis 88% at 5 year 5-year Survival Treatment of ovarian cancer: Considering the paradigm of ovarian cancer as a heterogenous disease that can be better managed through molecular stratification Stage I Stage II Stage III Stage IV Stage I Stage II Stage III Stage IV Uterine Cancer Histology Uterine Cancer: Risk Factors Taking estrogen alone without progesterone 75-8% Obesity Later menopause 3% 4% 1% 5% Endometrioid Mucinous Serous Clear cell Sarcomas Diabetes Never becoming pregnant Hypertension Family history of endometrial or colon cancer Use of tamoxifen
10 Endometrial Carcinoma Presentation Abnormal uterine bleeding Post-menopausal bleeding Irregular vaginal bleeding Uterine enlargement: variable Average age at diagnosis: 58 years Endometrial Cancer: Routine Screening is NOT recommended Screening test must be noninvasive Screening test must be inexpensive Detection of tumors at an early stage to allow more successful treatment 9% of women with endometrial cancer present with postmenopausal bleeding No satisfactory or cost-effective screening for endometrial cancer Consider ultrasound or biopsy for Lynch Syndrome family members Endometrial Cancer: Prevention Endometrial Cancer: Types I & II Obesity increases endometrial cancer risk by as much as 1-fold. Obesity may affect how cancer is treated (surgery, chemotherapy, radiation) and how well these treatments may work Diet, exercise, and weight loss may decrease risk of cancer, diabetes, heart disease, death 373 endometrial cancers: 37 endometrioid, 66 serous Tumor samples & corresponding germline DNA Median follow-up: 32 months (range 1-195) 21% patients with recurrence, 11% died Microsatellite instability in 4% of endometrioid tumors, 2% of serous tumors Narod et al, N Engl J Med, 1998 Nature 213
11 TCGA Endometrial Cancer Mutation Spectra across endometrial carcinomas POLE-mutant tumors have better progression-free survival All women with endometrial cancer should be evaluated for the possibility of Lynch Syndrome Tumor testing after clinical screening including personal & family medical history Tumor testing on all cases diagnosed before age 6 Tumor testing on all cases of endometrial cancer Lynch Syndrome Evaluation Prevalence of Lynch 543 endometrial cancer patients underwent microsatellite instability testing 118 (21.7%) MSI positive all underwent mutation testing 1 (1.8%) patients with deleterious germline mutation 9 of 118 MSI positive pts--mlh1, 3 MLH2, 5 MSH6 1 MSI stable tumor had absence of MSH6 on IHC confirmed on germline mutation Hampel et al, Cancer Res 26
12 Identification of Women at Risk N=117 women from Lynch families with dual gynecologic and colorectal cancers from 5 Lynch registries 14% patients with synchronous cancers 51% with gynecologic cancer first Median age 44, time to second cancer 11 yrs 49% with colon cancer first Median age 4, time to second cancer 8 yrs Colorectal Cancer Screening in Lynch Surveillance colonoscopy reduces mortality N=133, from 22 HNPCC families Compared to 119 controls who declined surveillance or could not be contacted Screening every 3 years: colonoscopy or flex sig + BE over 15 years Colorectal cancers incidence: 8/133 vs 19/119, p=.14 Relative risk of death:.344 (95% CI ) Lu et al, Obstet Gynecol 25 Jarvinen et al, Gastroenterology 2 Lynch Syndrome & Risk-reducing Surgery N=38 women with MLH1, MSH2, and MSH6 mutations from 3 HNPCC registries, Median age 41 years at prophylactic surgery Incidence of endometrial CA 46 at endometrial cancer diagnosis 42 at ovarian cancer diagnosis % after prophylactic hysterectomy (13 year follow-up) 33% controls (7 year follow-up) Incidence of ovarian CA % after prophylactic oophorectomy (11 yr follow-up) 5.4% controls (11 yr follow-up Schmeler et al, N Engl J Med, 26 Endometrial Cancer Take-home Summary Prevention of endometrial cancer: Endometrial cancer is associated with unopposed estrogen, exogenous or endogenous Prevention of of endometrial & other cancers: Identification of women with Lynch syndrome may allow screening and prevention of colorectal and endometrial cancer
13 Thank you! 49
Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationPrevention, Diagnosis and Treatment of Gynecologic Cancers
Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer
More informationDisclosure. Gynecologic Cancer Genetics. Audience response. Audience response. What was the result? 47%
Disclosure Cancer Genetics I have served as a moderator for an advisory board to Genentech Lee-may Chen, M.D. Professor Department of Obstetrics, Gynecology, & Reproductive Sciences UCSF Obstetrics and
More informationGYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer
GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer Causes of Hereditary Ovarian and Uterine Cancer uterine cancer ovarian cancer Sporadic 75-90% Sporadic 70-80% Hereditary, 5% Lynch syndrome
More informationKey Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer
Gynecologic management of women with inherited risk of gynecologic cancer C. Bethan Powell MD Kaiser Permanente Northern California Gynecologic Oncology Program Lead, Kaiser Permanente Northern California
More informationGYNplus. genetic testing for hereditary ovarian and/or uterine cancer
GYNplus genetic testing for hereditary ovarian and/or uterine cancer What Are the Causes of Hereditary Ovarian and Uterine Cancer? uterine cancer ovarian cancer sporadic 70-80% hereditary 5% Lynch syndrome
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationGynecologic Malignancies. Kristen D Starbuck 4/20/18
Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial
More informationGYNECOLOGIC MALIGNANCIES: Ovarian Cancer
GYNECOLOGIC MALIGNANCIES: Ovarian Cancer KRISTEN STARBUCK, MD ROSWELL PARK CANCER INSTITUTE DEPARTMENT OF SURGERY DIVISION OF GYNECOLOGIC ONCOLOGY APRIL 19 TH, 2018 Objectives Basic Cancer Statistics Discuss
More informationTHE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES
THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES Denise Uyar, MD Associate Professor OB/GYN Chief Gynecologic Oncology Medical College of Wisconsin April 12, 2019 NO DISCLOSURES
More informationOvarian Cancer Causes, Risk Factors, and Prevention
Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for ovarian cancer.
More informationUpdates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018
Updates in Gynecologic Oncology Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018 COI I have no conflict of interest to report Endometrial Cancer: Risk Factors
More informationSurgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk
Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk Centre for Genetics Education NSW Health 2017 The Centre for Genetics Education NSW Health Level 5 2C Herbert St St
More informationPartners: Introductions: Dr. Carolyn Johnston Deanna Cosens & Ann Garvin. Ovarian Cancer and Primary Care July 16, :00 9:00am EST 7/16/2014
Welcome To The Webinar Technical Support Ovarian Cancer and Primary Care July 16, 2014 8:00 9:00am EST In order to hear the presentation please call 1 (626) 544-0058, access code 167-314-644, followed
More informationIf you do not have time for the entire presentation refer to the following table of contents. To navigate through the slides, right click on your
Welcome This is an online version of a lecture given by Dr Keith Merritt on gyn cancers. Its purpose is to help women become more aware of early symptoms, risk factors, screening strategies and the importance
More informationKey Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer. HBOC related genes. I have nothing to disclose
Gynecologic management of women with inherited risk of gynecologic cancer C. Bethan Powell MD Kaiser Permanente Northern California Gynecologic Oncology Program I have nothing to disclose Key Recommendations
More informationMolly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine
Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine Review causes of abnormal uterine bleeding: Adolescent Reproductive
More informationOVARIAN CANCER Updates in Screening, Early Detection and Prevention
UW MEDICINE SUSAN PATRICIA TECK MEMORIAL LECTURE October 2017 OVARIAN CANCER Updates in Screening, Early Detection and Prevention BARBARA GOFF, MD Seattle Gynecologic Society March 2018 OVARIAN CANCER
More informationLynch Syndrome. Angie Strang, PGY2
Lynch Syndrome Angie Strang, PGY2 Background Previously hereditary nonpolyposis colorectal cancer Autosomal dominant inherited cancer susceptibility syndrome Caused by defects in the mismatch repair system
More informationPassport to Health Preventing and Recognizing Gynecologic Cancers
Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can
More informationBRCAplus. genetic testing for hereditary breast cancer
BRCAplus genetic testing for hereditary breast cancer Developed in collaboration with Fox Chase Cancer Center and the Arcadia University Genetic Counseling Program. Causes of Hereditary Breast Cancer familial
More informationMenopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D
Menopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D Menopause and Cancer How does menopause affect a woman s cancer risk? Ø Menopause does not cause cancer.but risk of developing
More informationWhat You Need to Know About Ovarian Cancer
What You Need to Know About Ovarian Cancer About Us The Rhode Island Ovarian Cancer Alliance (RIOCA) was formed in honor and memory of Jessica Morris. Jessica was diagnosed with Stage IIIC Ovarian Cancer
More informationPrimary Care Approach to Genetic Cancer Syndromes
Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
More informationIs It Time To Implement Ovarian Cancer Screening?
Is It Time To Implement Ovarian Cancer Screening? Prof Dr Samet Topuz Istanbul Medıcal Faculty Department Of Obstetrics and Gynecology ESGO Prevention in Gynaecological Malignancies September 08 2016 Antalya
More informationTumori eredofamiliari: sorveglianza di donne ad alto rischio
Tumori eredofamiliari: sorveglianza di donne ad alto rischio 14/01/2018 Dott Matteo Generali AUSL Modena Carpi U.O. Ostetricia e Ginecologia Screening for gynaecologic cancer in genetically predisposed
More informationInherited Breast and Ovarian Cancer: 20 Years of Progress and Future Directions
Inherited Breast and Ovarian Cancer: 20 Years of Progress and Future Directions Noah D. Kauff, MD, FACOG Director, Clinical Cancer Genetics Duke Cancer Institute / Duke University Health System Disclosures
More informationHereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com
Hereditary Cancer Risk Assessment for Gynecological Cancers FarrNezhatMD.com Image credit: PLOS blogs 5-10% hereditary 10-20% 70-80% sporadic Genetic Changes and Cancer Cancer begins with a genetic
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME GENE DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationGenetic Determinants, Risk Assessment and Management
Genetic Determinants, Risk Assessment and Management Rachel Rando, MS, CGC Genetic Counselor Hunterdon Regional Cancer Center Flemington, NJ I have no disclosures. Acknowledgements: Staff of Hunterdon
More informationEpithelial Ovarian Cancer 8/2/2013. Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer?
Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer? Ann E. Smith Sehdev, MD Director, Center for Gynecologic Pathology Cascade Pathology, Portland, Oregon Ann E. Smith Sehdev has no
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationGenetic Testing For Ovarian Cancer: When, How And Who? Judith Balmaña, MD, PhD University Hospital Vall d Hebron Barcelona, Spain
Genetic Testing For Ovarian Cancer: When, How And Who? Judith Balmaña, MD, PhD University Hospital Vall d Hebron Barcelona, Spain Why Would We Consider Genetic Testing in Patients With Ovarian Cancer?
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationUniversity Gynecologic Oncology Associates
University Gynecologic Oncology Associates Medical History Form Date: Name: Date of Birth: / / GYNE HISTORY Age of first period? If you no longer have periods, at what age did they stop? Are you pregnant
More informationHow common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.
The gene is a tumor suppressor gene. Tumor suppressor genes slow down cell division, repair DNA mistakes, or tell cells when to die. When they don't work properly, cells can grow out of control, which
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationManagement of Endometrial Hyperplasia
Management of Endometrial Hyperplasia I have nothing to disclose. Stefanie M. Ueda, M.D. Assistant Clinical Professor UCSF Division of Gynecologic Oncology Female Malignancies in the United States New
More informationEDUCATIONAL COMMENTARY CA 125. Learning Outcomes
EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationBSO, HRT, and ERT. No relevant financial disclosures
BSO, HRT, and ERT Jubilee Brown, MD Professor & Associate Director, Gynecologic Oncology Levine Cancer Institute at the Carolinas HealthCare System Charlotte, North Carolina No relevant financial disclosures
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationContent. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome
of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines
More informationProtect & Detect: What Women should Know about cancer. The American College of Obstetricians and Gynecologists
Protect & Detect: What Women should Know about cancer The American College of Obstetricians and Gynecologists A Message From ACOG President Kenneth L. Noller, MD Dr. Noller is the Louis E. Phaneuf professor
More informationGynecologic Decision Making Based on Sonographic Findings
Gynecologic Decision Making Based on Sonographic Findings Mindy Goldman, MD Department of Obstetrics & Gynecology & Vickie A. Feldstein, MD Department of Radiology University of California, San Francisco
More informationGynecological Cancers
Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and
More informationRAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015.
RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. AIMS AND OBJECTIVES OF THE NEXT ½ HOUR. Brief overview of the different types of gynaecological cancers
More information6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017
Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA
More informationFAQ-Protocol 3. BRCA mutation carrier guidelines Frequently asked questions
ULast updated: 09/02/2015 Protocol 3 BRCA mutation carrier guidelines Frequently asked questions UQ: How accurate are the remaining lifetime and 5 year breast cancer risks in the table? These figures are
More informationScreening and prevention of ovarian cancer
Chapter 2 Screening and prevention of ovarian cancer Prevention of ovarian carcinoma Oral contraceptive pills Use of oral contraceptive pills (OCPs) has been associated with a significant reduction in
More informationArdhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
More informationCurrent Concept in Ovarian Carcinoma: Pathology Perspectives
Current Concept in Ovarian Carcinoma: Pathology Perspectives Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine Current Concept in Ovarian
More informationWhy Test for Hereditary Cancer in Preventive Care?
Why Test for Hereditary Cancer in Preventive Care? Millions of people are sidelined by cancer. Wouldn't it be worth it for your patients to know their risk? background HEREDITARY (5-10%) More than 1 in
More informationGenetic Risk Assessment for Cancer
Genetic Risk Assessment for Cancer Jennifer Siettmann, MS CGC Certified Genetic Counselor/Cancer Risk Counselor Banner Good Samaritan Cancer Screening & Prevention Program Objectives Describe the role
More informationInherited Ovarian Cancer Diagnosis and Prevention
Inherited Ovarian Cancer Diagnosis and Prevention Dr. Jacob Korach - Deputy director Gynecologic Oncology (past chair - Israeli Society of Gynecologic Oncology) Prof. Eitan Friedman - Head, Oncogenetics
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More informationHereditary Cancer Update Strengthening Linkages Workshop April 22, 2017
Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017 Renée Perrier, MD MSc FRCPC Clinical Assistant Professor University of Calgary, Department of Medical Genetics Medical Director,
More informationACCME/Disclosures. Risk of Gyne Ca in HBOC. Molecular basis of HBOC. Hereditary Ovarian and Breast Cancer Syndrome
Hereditary Ovarian and Breast Cancer Syndrome C. Blake Gilks, MD Dept of Pathology Vancouver General Hospital University of British Columbia Blake.gilks@vch.ca The USCAP requires that anyone in a position
More informationOvaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital
Ovaries: In Sickness and Health Mr N Pisal Consultant Gynaecologist The Portland Hospital Topics for discussion How to assess ovarian function? AMH PCOS Ovarian pain Ovarian cysts Ovarian screening Menopause
More informationGynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1
What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical
More informationEndometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.
Endometrial cancer Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology dr.mate.szabolcs@gmail.com Epidemiology Developing countries Cervical cancer is the most common gyn. malignant tumor
More informationUnderstanding and Managing Lynch Syndrome
Understanding and Managing Lynch Syndrome Princess Margaret For women who may have Lynch syndrome and their family members Please visit the UHN Patient Education website for more health information: www.uhnpatienteducation.ca
More informationGEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics
GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics The Medical/Surgical/Radiation Oncologist s View of Genetics Cancer
More informationARRO Case: Early-stage Endometrial Cancer
ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American
More informationLong-Term Health Outcomes of Surgical Menopause
Long-Term Health Outcomes of Surgical Menopause Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences University of California, San Francisco None Disclosures Overview
More informationHitting the High Points Gynecologic Oncology Review
Hitting the High Points is designed to cover exam-based material, from preinvasive neoplasms of the female genital tract to the presentation, diagnosis and treatment, including surgery, chemotherapy, and
More informationTriage of Ovarian Masses. Andreas Obermair Brisbane
Triage of Ovarian Masses Andreas Obermair Brisbane Why Triage? In ovarian cancer, best outcomes for patients can be achieved when patients are treated in tertiary centres by a multidisciplinary team led
More informationUTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma
UTERINE LEIOMYOSARCOMA Uterine Lms, Ulms Or Just Lms Rare uterine malignant tumour that arises from the smooth muscular part of the uterine wall. Diagnosis Female About Uterine leiomyosarcoma Uterine LMS
More informationImportance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC
Importance of Family History in Gynecologic Cancer Prevention Angela Thompson, MS, CGC Genetic Counselor Froedtert & The Medical College of Wisconsin Objectives Introduce role of genetic counselor Discuss
More informationOBJECTIVES 8/25/2017. An attempt to organize the chaos
High Risk for Breast Cancer and Genetics: Who? What? Where? When? An attempt to organize the chaos Presented at Winds of Change Conference November 3, 2017 by Carol Hager, MSN, CRNP and Allison Haener,
More informationHereditary Cancer Update: What do GPOs need to know?
Hereditary Cancer Update: What do GPOs need to know? Mary McCullum, RN, MSN, CON(C) Nurse Educator, Hereditary Cancer Program BC Cancer Agency October 1, 2016 Conflict of Interest Disclosure Nothing to
More informationOvarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center
Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade
More informationX-Plain Ovarian Cancer Reference Summary
X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference
More informationTerminology in Health Care and Public Health Settings
Terminology in Health Care and Public Health Settings Unit 10 Reproductive Systems 1 Female and Male Reproductive Systems Objectives Define, understand and correctly pronounce medical terms related to
More informationPolicy #: 259 Latest Review Date: November 2009
Name of Policy: Prophylactic Oophorectomy Policy #: 259 Latest Review Date: November 2009 Category: Surgery Policy Grade: Active Policy but no longer scheduled for regular literature reviews and updates.
More informationThe Role of Genetics in Ovarian Cancer Screening. Dawn DeLozier, Ph.D. Medical Geneticist, SAMC Associate Professor UCSF-Fresno
The Role of Genetics in Ovarian Cancer Screening Dawn DeLozier, Ph.D. Medical Geneticist, SAMC Associate Professor UCSF-Fresno How Much Breast and Ovarian Cancer Is Hereditary? 15%-20% 5%-10% Breast Cancer
More informationHereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG
Hereditary Breast and Ovarian Cancer 2015 Rebecca Sutphen, MD, FACMG Among a consecutive series of 11,159 women requesting BRCA testing over one year, 3874 responded to a mailed survey. Most respondents
More informationObjectives. Case Study #1 1/28/14. A Collaborative Practice Approach to Genetic Testing in Cancer: Translating Science Into Clinical Practice
A Collaborative Practice Approach to Genetic Testing in Cancer: Translating Science Into Clinical Practice Heather Hampel, MS, CGC Associate Director, Division of Human Genetics Professor, Department of
More informationA Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?
A Patient s Guide to Hereditary Cancer Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer. This is
More informationCancer Genomics 101. BCCCP 2015 Annual Meeting
Cancer Genomics 101 BCCCP 2015 Annual Meeting Objectives Identify red flags in a person s personal and family medical history that indicate a potential inherited susceptibility to cancer Develop a systematic
More informationCancer Awareness Talk ICPAK 2014
Cancer Awareness Talk ICPAK 2014 F. Chite Asirwa, MB ChB. MD. MSc. Internist. Medical Oncologist & Hematologist Asst. Professor of Medicine Division of Hematology/Oncology Indiana University Email: fasirwa@iu.edu
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationCervical Cancer - Suspected
Cervical Cancer - Suspected Presentation for patients Asymptomatic presentation Symptomatic presentation History and examination Consider differential diagnoses RED FLAG! Cervix appears normal after examination
More informationGynecologic Cancers. Marcella Williams, MS, RN, AOCN
This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies,
More informationNew Patient History. Patient Name: Date of Birth: Reason for Today s Visit: Today s Date: Who is your Primary Care Physician (PCP)?
ew Patient History Patient ame: Date of Birth: Reason for Today s Visit: Today s Date: Who is your Primary Care Physician (PCP)? Review of Systems Please circle any concerning symptoms you are currently
More informationThe Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto
Immunohistochemical Assessment of Mismatch Repair Proteins in Endometrial Cancer: The Whys and How Terence J. Colgan, MD Head of Gynaecological Pathology, Mount Sinai Hospital, University of Toronto, Toronto.
More informationShina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya
Comparison of Synchronous Endometrial and Ovarian Cancers versus Primary with Metastasis RESEARCH COMMUNICATION Clinicopathologic Variables and Survival Comparison of Patients with Synchronous Endometrial
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationHereditary Gynecologic Cancer 15 Years of Progress
Hereditary Gynecologic Cancer 15 Years of Progress Bethan Powell, M. D. Kaiser Permanente UCSF Gynecologic Cancer Risk Program Hereditary Gynecologic Cancer Syndromes BRCA 1 and 2: ovarian Lynch: ovarian/endometrial
More informationCase Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr
Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Professor Yong Loo Lin School of Medicine, National University
More informationPractice of Medicine-1 Ovarian Cancer Clinical Correlation
Practice of Medicine-1 Ovarian Cancer Clinical Correlation Amir A. Jazaeri, M.D. Assistant Professor, Division of Gynecologic Oncology American Cancer Society Female Cancers 2000 Statistics Reprinted by
More informationProtocols 9-12 MMR mutation carrier guidelines Frequently asked questions
Protocols 9-12 MMR mutation carrier guidelines Frequently asked questions Last updated: 10/02/2015 Q: Where have the general population cancer risks been taken from? The risk figures for the general population
More informationGenetic Testing: who, what, why?
Genetic Testing: who, what, why? Gina Westhoff MD LMG Gynecologic Oncology March 16, 2019 Disclosures Speaker for Merck (unrelated to today s topic) Objectives Determine who should undergo genetic risk
More informationMajor tips: The importance of early detection: Hx, risk factors
Cancer Chapter 3 Introduction Cancer ranks 2nd to cardiovascular disease as the leading cause of death in the Gaza Strip. Death rate increased from 10.3% in 2007 to 13.6 in 2012. Some related factors :
More informationGenetic Risk Assessment for Cancer
Genetic Risk Assessment for Cancer Jennifer Siettmann, MS CGC Certified Genetic Counselor Banner MD Anderson Cancer Center Objectives Describe the role of genetic counseling and genetic testing in patient
More informationEvaluation of BRCA1/2 and homologous recombination defects in ovarian cancer and impact on clinical outcomes
Evaluation of BRCA1/2 and homologous recombination defects in ovarian cancer and impact on clinical outcomes Melinda S. Yates, PhD Department of Gynecologic Oncology & Reproductive Medicine University
More informationCancer Facts for Women
Cancer Facts for Women Some of the cancers that most often affect women are breast, colorectal, endometrial, lung, cervical, skin, and ovarian cancers. Knowing about these cancers and what you can do to
More information